Follow us on:

Linkedin Facebook

Midatech Pharma to release its interim results on 17th September 2021

Midatech Pharma
[shareaholic app="share_buttons" id_name="post_below_content"]

Midatech Pharma PLC (LON:MTPH), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, has announced that it will release its interim results for the six months ended 30 June 2021 at 7.00 am BST on Friday 17 September 2021.

Midatech Pharma will be hosting a webinar at 5.30pm BST / 12.30pm EST on Monday 20 September 2021. The webinar is open to all existing and potential shareholders and those interested in attending may register via the following link where, following registration, they will be provided with access details:

https://us02web.zoom.us/webinar/register/WN_vLpYaALlRYqUXveBsffy7w

Participants may submit questions during the webinar or in advance via email to: [email protected]

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Midatech Pharma

    Midatech Pharma Phase I study of MTX-110 in rGB will continue with a planned dose escalation

    Midatech Pharma

    Midatech Pharma to acquire Bioasis Technologies Inc.

    Midatech Pharma

    Midatech Pharma pleased with the progress made in H1 2022

    Midatech Pharma

    Midatech Pharma MTX110 development programme granted Orphan designation by EMA

    Boardroom

    Midatech Pharma appoints Dr Stephen Parker as Non-Executive Chairman

    Midatech Pharma

    Midatech Pharma MTX110 study to be presented at ISPNO 2022

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.